Maxwell R E, Nawrocki J W, Uhlendorf P D
Atherosclerosis. 1983 Sep;48(3):195-203. doi: 10.1016/0021-9150(83)90038-2.
Liver cholesterogenesis in rats was measured by giving [l-14C]octanoate i.p.; 1 h later digitonin-precipitable sterols were isolated and counted. In rats fed normal chow and given 7 daily p.o. doses of compounds and then fasted, at 20 h after the last dose, clofibrate or bezafibrate had no effect at lower doses or inhibited incorporation at higher doses, while compactin or gemfibrozil caused increases; cholestyramine added to the diet also caused marked increases. When rats were fed chow containing 0.1% cholesterol and 5.5% peanut oil, again at 20 h following the last of 7 daily doses, gemfibrozil caused increases of incorporation which diminished at higher levels of dosage, while clofibrate caused only inhibition. A single dose of gemfibrozil caused inhibition at 3 h postdose followed by increases over control at 36 and 48 h; a single dose of compactin caused inhibition at 3 h but not subsequent increase, and a single dose of clofibrate had no effect over the entire period. In rats fed chow containing 1.5% cholesterol and 5.5% peanut oil, gemfibrozil given orally or cholestyramine in the diet prevented the diet-induced decreases of plasma HDL cholesterol and increases of liver cholesterol content, while bezafibrate treatment did not have those effects. The effects of cholestyramine rapidly disappeared when it was withdrawn from the diet, while the effects of gemfibrozil persisted after dosage was stopped. These results suggest that some of the actions of gemfibrozil on rat sterol metabolism are quantitatively different from those of the other agents tested.
通过腹腔注射[1-14C]辛酸来测定大鼠肝脏胆固醇的合成;1小时后分离并计数洋地黄皂苷可沉淀的固醇。给喂食普通食物的大鼠每日口服7次化合物,然后禁食,在最后一剂后的20小时,氯贝丁酯或苯扎贝特在较低剂量时无作用,而在较高剂量时抑制掺入,而美伐他汀或吉非贝齐则导致增加;饮食中添加消胆胺也导致显著增加。当给大鼠喂食含0.1%胆固醇和5.5%花生油的食物时,同样在每日7剂中的最后一剂后的20小时,吉非贝齐导致掺入增加,在较高剂量时这种增加减弱,而氯贝丁酯仅引起抑制作用。单次给予吉非贝齐在给药后3小时引起抑制,随后在36小时和48小时超过对照水平增加;单次给予美伐他汀在3小时引起抑制,但随后没有增加,单次给予氯贝丁酯在整个期间没有作用。在喂食含1.5%胆固醇和5.5%花生油食物的大鼠中,口服吉非贝齐或饮食中添加消胆胺可预防饮食诱导的血浆高密度脂蛋白胆固醇降低和肝脏胆固醇含量增加,而苯扎贝特治疗则没有这些作用。当消胆胺从饮食中撤出时,其作用迅速消失,而吉非贝齐的作用在停药后持续存在。这些结果表明,吉非贝齐对大鼠固醇代谢的一些作用在数量上与其他受试药物不同。